These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10476769)
1. Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community. McMinn P; Carrello A; Cole C; Baker D; Hampson A Clin Infect Dis; 1999 Aug; 29(2):456-8. PubMed ID: 10476769 [No Abstract] [Full Text] [Related]
2. Seroepidemiologic study on influenza A (H1N1) virus infection among school children after an "antigenic shift" from A (H3N2) to a (H1N1) in Kukuoka of southern Japan in 1978. Tokugawa K; Ueda K; Sakoh M; Yoshikawa H; Nonaka S Pediatr Infect Dis J; 1987 Aug; 6(8):761-2. PubMed ID: 3670940 [No Abstract] [Full Text] [Related]
3. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination]. Stumpa A; Tůmová B Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986 [No Abstract] [Full Text] [Related]
4. Antigenic variation of influenza A (H3N2) virus in relation to influenza epidemics in Shanghai (1968-1977). Shen FZ; Wang MH Chin Med J (Engl); 1985 Feb; 98(2):83-8. PubMed ID: 3922694 [No Abstract] [Full Text] [Related]
5. Antigenic analysis of influenza A(H3N2) isolates. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Apr; 31(15):189. PubMed ID: 6808334 [No Abstract] [Full Text] [Related]
6. [Comparison of characterization of hemagglutination and HA1 sequence of currently circulating strains of influenza A (H3N2) virus in Zhejiang province and in Japan]. Lu YY; Yan JY; Zhou M; Jiang XL Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):15-8. PubMed ID: 12678955 [TBL] [Abstract][Full Text] [Related]
7. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species. Yassine HM; Lee CW; Suarez DL; Saif YM Vaccine; 2008 Feb; 26(7):966-77. PubMed ID: 18206275 [TBL] [Abstract][Full Text] [Related]
8. High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmission. Pan C; Wang G; Liao M; Zhang GH; Jiang S Biochem Biophys Res Commun; 2009 Jul; 385(3):402-7. PubMed ID: 19463787 [TBL] [Abstract][Full Text] [Related]
9. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239 [TBL] [Abstract][Full Text] [Related]
10. Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end. Hungnes O Vaccine; 2006 Nov; 24(44-46):6694-6. PubMed ID: 16920231 [TBL] [Abstract][Full Text] [Related]
12. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. Besselaar TG; Botha L; McAnerney JM; Schoub BD J Med Virol; 2004 May; 73(1):71-8. PubMed ID: 15042651 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology. Influenza escapes immunity along neutral networks. van Nimwegen E Science; 2006 Dec; 314(5807):1884-6. PubMed ID: 17185589 [No Abstract] [Full Text] [Related]
14. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. Huber VC; McCullers JA J Infect Dis; 2006 Mar; 193(5):677-84. PubMed ID: 16453263 [TBL] [Abstract][Full Text] [Related]
15. [Effect of the host on the phase transformations of an influenza virus population]. Skripchenko GS; Vlasova AG; Rybakova TM Vestn Akad Med Nauk SSSR; 1983; (5):28-34. PubMed ID: 6868801 [No Abstract] [Full Text] [Related]
16. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
17. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
18. Influenza vaccine 2008-2009. Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032 [TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208 [TBL] [Abstract][Full Text] [Related]
20. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population. Nakajima S; Nobusawa E; Nakajima K Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]